AnalystsKumaraguru RajaKumaraguru Raja's Stock Forecasts
AnalystsKumaraguru Raja
Sectors:
Industries:
Analyst Ranking
Bottom 2%
#5082 out of 5153 analysts
Average Return
-36.36%
Win Rate
17%4 out of 23
Risk vs Reward
Poor
Good
Kumaraguru Raja's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Palisade Bio IncPALI | +147.95% | $0.73 | $1.81 | 2025-05-12 - 2025-12-15 | Strong Buy |
Quince Therapeutics IncQNCX | +103.78% | $1.85 | $3.77 | 2024-12-17 - 2025-12-15 | Strong Buy |
Intensity Therapeutics IncINTS | +44.22% | $0.29 | $0.42 | 2025-08-12 - 2025-12-15 | Strong Buy |
Veru IncVERU | +29.07% | $22.70 | $29.30 | 2019-07-29 - 2020-07-30 | Strong Buy |
Kumaraguru Raja Analyst Color
Get additional color on Kumaraguru Raja's coverage of popular stocks
Kumaraguru Raja's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Intensity Therapeutics IncINTS | 1 | Strong Buy | $3.00 | +607.55% | Upgrades | 4 months ago |
Palisade Bio IncPALI | 2 | Strong Buy | $16.00 | +783.98% | Maintains | 7 months ago |
Quince Therapeutics IncQNCX | 1 | Strong Buy | $9.00 | +138.73% | Initiates Coverage On | a year ago |
Sab Biotherapeutics IncSABS | 1 | Strong Buy | $8.00 | N/A | Initiates Coverage On | 2 years ago |
Forte Biosciences IncFBRX | 2 | Strong Buy | $100.00 | N/A | Initiates Coverage On | 2 years ago |
Adial Pharmaceuticals IncADIL | 2 | Strong Buy | $150.00 | N/A | Reiterates | 2 years ago |
Genenta Science SpaGNTA | 1 | Strong Buy | $15.00 | N/A | Assumes | 2 years ago |
Atyr Pharma IncATYR | 1 | Strong Buy | $9.00 | N/A | Reinstates | 3 years ago |
Rain Oncology IncRAIN2 | 1 | Strong Buy | $21.00 | N/A | Reinstates | 3 years ago |
Apexigen IncAPGN | 1 | Strong Buy | $15.00 | N/A | Reinstates | 3 years ago |
Monopar TherapeuticsMNPR | 2 | Strong Buy | $90.00 | N/A | Reinstates | 3 years ago |
Veru IncVERU | 2 | Strong Buy | $310.00 | N/A | Maintains | 4 years ago |
Dermata Therapeutics IncDRMA | 1 | Strong Buy | $33,600.00 | N/A | Initiates Coverage On | 4 years ago |
Oncternal Therapeutics IncONCT | 1 | Strong Buy | $320.00 | N/A | Initiates Coverage On | 5 years ago |
9 Meters Biopharma IncNMTRQ | 1 | Strong Buy | $120.00 | N/A | Assumes | 5 years ago |
Newcelx LtdNCEL | 1 | Strong Buy | $480.00 | N/A | Initiates Coverage On | 5 years ago |
Lisata Therapeutics IncLSTA | 1 | Strong Buy | $10.00 | N/A | Maintains | 5 years ago |
Cns Pharmaceuticals IncCNSP | 1 | Strong Buy | $9,000,000.00 | N/A | Initiates Coverage On | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.